ANEST IWATA Corporation
Financial Results Briefing Materials for Fiscal Year Ending March 2026
For the fiscal year ending March 2026, sales are projected to be approximately 5.59 billion yen, operating profit approximately 556 million yen, and net income approximately 216 million yen. Sales are expected to increase by 2.8% year-over-year, and net income by 25.2%. This term aims to expand profits through domestic and international business expansion and strengthened investments.
Key Figures
- Sales: 5.59 billion yen (Up 2.8% YoY)
- Operating Profit: 556 million yen (Up 8.1% YoY)
- Net Income: 216 million yen (Up 25.2% YoY)
AI要約
Performance Overview
Anest Iwata announced consolidated financial forecasts for the fiscal year ending March 2026, projecting sales of approximately 5.59 billion yen, operating profit of approximately 556 million yen, and net income of approximately 216 million yen. Sales are expected to increase by 2.8% compared to the same period of the previous year, with operating profit rising by 8.1% and net income increasing by 25.2%, indicating strong growth. The company is aiming to expand profits through domestic and international business expansion and enhanced investments.
Future Outlook and Investor Impact
This fiscal year, the company plans to increase earnings through domestic and international business expansion and stronger investments. Particularly, expanding overseas operations and new investments will help build a long-term growth foundation, while maintaining shareholder returns and dividend policies. For investors, stable earnings growth and anticipated dividend increases make this an attractive long-term investment opportunity, enhancing the company's long-term value.
Anest Iwata Corporation
Company overview · Stock price · Financial data · All IR
